Treatment-free remission in patients with prior tyrosine kinase inhibitor failure is not influenced by previous BCR::ABL1 kinase domain mutations

British Journal of Haematology , Oct 2026

Claudiani S et al. Br J Haematol, September 2026 (epub ahead of print)

Link to full abstract